US8945642B2 - Nutritionally enhanced isolate from stabilized rice bran and method of production - Google Patents
Nutritionally enhanced isolate from stabilized rice bran and method of production Download PDFInfo
- Publication number
- US8945642B2 US8945642B2 US12/882,202 US88220210A US8945642B2 US 8945642 B2 US8945642 B2 US 8945642B2 US 88220210 A US88220210 A US 88220210A US 8945642 B2 US8945642 B2 US 8945642B2
- Authority
- US
- United States
- Prior art keywords
- slurry
- rice bran
- protease
- stabilized rice
- range
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
Classifications
-
- A23L1/1016—
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/115—Cereal fibre products, e.g. bran, husk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
-
- A23L1/095—
-
- A23L1/1055—
-
- A23L1/3002—
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
- A23L7/107—Addition or treatment with enzymes not combined with fermentation with microorganisms
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/02—Pretreatment
- C11B1/025—Pretreatment by enzymes or microorganisms, living or dead
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to a process of producing a nutritionally enhanced derivative (isolate) from Stabilized Rice Bran (SRB) with improved yield characteristics.
- Rice bran is a nutrient-dense composition derived from the milling of rice.
- Rice bran is a rich source of protein, fat, carbohydrate and a number of micronutrients such as vitamins, minerals, anti-oxidants and phytosterols.
- rice bran To be useful as a food ingredient, rice bran must be stabilized. That is, the lipid hydrolyzing and oxidizing enzymes present in the bran must be inactivated in order to prevent interaction of those enzymes, lipase and peroxidase in particular, with the oil fraction. If these enzymes are not inactivated, hydrolytic and oxidative rancidity will proceed, causing the formation of objectionable odors and flavors commonly associated with rancidity.
- rice bran serves as a dietary nutrient useful in a variety of food and beverage formulations.
- SRB Stabilized Rice Bran
- the nutrients in SRB are preferably extracted into a concentrated isolate for use in commercial food and beverage formulations.
- existing processes for the production of SRB derivatives provide inefficient yields and limited nutritional profiles compared to the potential available in SRB.
- the enzyme alpha-amylase has been used to treat an aqueous slurry of SRB to convert the starch component of the SRB into a dextrin slurry that can be isolated by centrifugation and subsequent drying.
- the resulting dextrin product typically represents only forty to fifty percent of the starting weight of the SRB, and unlike nutrient-rich SRB, the dextrin product has a limited nutritional profile and is low in protein and antioxidant rich fat content.
- the fat content in SRB has special qualities that can be maximized to enhance the nutraceutical nutritional value of the dextrin isolate.
- the fat/oil component of SRB is dense with numerous antioxidants that provide SRB with an extremely high nutraceutical nutritional capacity.
- the antioxidant capacity of SRB is several magnitudes higher than foods more commonly known to be high in antioxidants. For instance, Xianli Wu et al., in the Journal of Food Composition and Analysis 17 (2004) at pages 407-422 (incorporated herein by reference), listed total antioxidant capacity (hydrophilic and lipophylic ORAC FL ) of 28 selected foods.
- a nutritionally enhanced derivative (isolate) from SRB with improved yield characteristics and method for producing same.
- a nutritionally enhanced isolate of Stabilized Rice Bran is provided, which is prepared by a process comprising the steps of: providing a Stabilized Rice Bran material; adding water to the Stabilized Rice Bran material to produce a slurry including an insoluble fiber fraction; adding a beta-glucanase enzyme to the slurry; heating the slurry sufficiently to activate the beta-glucanase enzyme to release fat components from the insoluble fiber fraction into a soluble fat fraction; and isolating the soluble fat fraction.
- the nutritionally enhanced isolate of Stabilized Rice Bran may then, in certain embodiments, be further prepared by a process further comprising the steps of: adding a protease enzyme to the slurry; heating the slurry sufficiently to activate the protease enzyme to create a soluble protein fraction from the Stabilized Rice Bran material; and isolating the soluble protein fraction.
- the nutritionally enhanced isolate of Stabilized Rice Bran may in certain embodiments be prepared by a process further comprising the steps of: adding an alpha amylase enzyme to the slurry; heating the slurry sufficiently to activate the alpha amylase enzyme to convert starch in the Stabilized Rice Bran material into a soluble dextrin fraction; and isolating the soluble dextrin fraction.
- the nutritionally enhanced isolate of Stabilized Rice Bran may in certain embodiments be prepared by a process further comprising the steps of: heating the slurry to a first temperature for a first time period; and heating the slurry to a second temperature for a second time period.
- the first temperature may be selected from a range of about 50° C. to 110° C., for instance, in certain embodiments from a range of about 57° C. to 97° C.
- the first time period may be no less than about 1 minute and no more than about 120 minutes, for instance, in certain embodiments no less than about 15 minutes and no more than about 45 minutes.
- the second temperature may be selected from a range of about 50° C.
- the second time period may be no less than about 1 minute and no more than about 120 minutes, for instance, in certain embodiments from no less than about 1 minute and no more than about 10 minutes.
- the slurry may in various embodiments have a pH selected from a range of about 3.0 to about 7.5, for instance, in certain embodiments from a range of about 6.0 to about 7.0.
- a nutritionally enhanced isolate of Stabilized Rice Bran is provided, which is prepared by a process comprising the steps of: providing a Stabilized Rice Bran material; adding water to the Stabilized Rice Bran material to produce a slurry; adding a beta-glucanase enzyme to the slurry; heating the slurry sufficiently to activate the beta-glucanase enzyme to create a soluble fiber fraction from the Stabilized Rice Bran material; and isolating the soluble fiber fraction. All of the aforementioned aspects may apply to these embodiments.
- Also provided is a method of creating a nutritionally enhanced isolate of Stabilized Rice Bran comprising the steps of: providing a Stabilized Rice Bran material; adding water to the Stabilized Rice Bran material to produce a slurry; adding a protease enzyme to the slurry; heating the slurry sufficiently to activate the protease enzyme to create a soluble protein fraction from the Stabilized Rice Bran material; and isolating the soluble protein fraction.
- the method may further comprise the steps of: adding a beta-glucanase enzyme to the slurry; heating the slurry sufficiently to activate the beta-glucanase enzyme to create a soluble fiber fraction from the Stabilized Rice Bran material; and isolating the soluble fiber fraction.
- the method may further comprise the steps of: adding an alpha amylase enzyme to the slurry; heating the slurry sufficiently to activate the alpha amylase enzyme to convert starch in the Stabilized Rice Bran material into a soluble dextrin fraction; and isolating the soluble dextrin fraction.
- the enzyme alpha-amylase has been used to convert the starch component of SRB into a dextrin product lacking in protein, fat, and fiber content.
- the present invention overcomes this limitation by utilizing additional enzymes under a range of conditions to convert protein and fiber in the SRB to less complex fractions that can be isolated from insoluble fractions by screening and centrifuging.
- This new process is referred to herein as the Enhanced Enzyme Treatment and includes treating SRB slurries with certain enzymes in single or multiple process steps to facilitate isolation and inclusion of protein and fiber into the dextrin fraction from SRB. With the inclusion of the protein, fat, and fiber fractions, the yield of the finished product is significantly increased in quantity and improved in nutritional quality.
- EET An example Enhanced Enzyme Treatment
- SI Standard Isolate
- NAI Nutritionally Enhanced Isolate
- the Stabilized Rice Bran was obtained from NutraCea, which has a location at 6720 N. Scottsdale Road, Suite 390, Scottsdale, Ariz. 85253.
- NutraCea's SRB is a shelf stable, USDA approved food-grade ingredient obtained from the vitamin rich outer layers of whole rice. Because nutrients contained in the outer layers of rice bran are very delicate, the rice bran is carefully milled and processed to maximize its freshness and retain its wholesomeness. While SRB from NutraCea was used in this example, the invention is not limited to use of that product, and it will be apparent to persons skilled in the art that other suitable SRB products can be used.
- THERMOSTABLE AMYLASE HTL was obtained from BIO-CAT INC., located at 9117 Three Notch Road, Troy, Va. 22974.
- THERMOSTABLE AMYLASE HTL is an endo-amylase derived from a genetically modified strain of Bacillus licheniformis . This product exhibits high heat and low pH stability in starch hydrolysis and does not require additional calcium for operating under industrial liquefaction conditions.
- THERMOSTABLE AMYLASE HTL randomly hydrolyzes alpha-1,4-glucosidic bonds to reduce the viscosity of gelatinized starch and produce soluble dextrins and oligosaccharides. BIO-CAT INC.
- BIO-CAT INC. recommends a temperature range of 105° C. to 110° C. for 5 to 7 minutes for primary liquefaction, and for secondary liquefaction a temperature range of 95° C. for 90 to 120 minutes (wet mill) and 85° C. to 93° C. for 90 to 120 minutes (dry mill).
- THERMOSTABLE AMYLASE HTL is supplied as a brown liquid that is standardized to not less than 17,400 LU/g.
- One Liquefon Unit is the measure of the digestion time required to produce a color change with iodine solution, indicating a definite stage of dextrinizotion of starch substrate under specified conditions.
- the optimum dosage of THERMOSTABLE AMYLASE HTL will vary with differences in substrate, pH, temperature, and processing time. While THERMOSTABLE AMYLASE HTL was used in this example, the invention is not limited to use of that product, and it will be apparent to persons skilled in the art that other suitable enzyme products can be used, including other alpha amylase enzyme products.
- the slurry was then transferred to four fifty-milliliter centrifuge tubes to a starting weight of forty-five grams each.
- the four tubes were then placed in a high-speed centrifuge (International Equipment Company Model CS) and spun at 5,000 revolutions per minute for five minutes.
- the aqueous fraction containing the soluble isolates were decanted from each tube and recorded for weight.
- the aqueous fractions from each tube were then combined and tested for percent solids, percent fat and percent protein to determine baseline data for a Standard Isolate treated according to this Standard Enzyme Treatment. The results for these combined fractions of Standard Isolate are recorded in Table 1 as Sample 1.
- EET Enhanced Enzyme Treatment
- SRB Nutritionally Enhanced Isolate
- EET Enhanced Enzyme Treatment
- One-hundred grams of SRB (described above) was treated with four-hundred grams of water to produce a twenty percent solids slurry in a 1,000 milliliter beaker.
- the pH value of the resulting slurry measured 6.81 at 25° C.
- To the slurry was added one gram of THERMOSTABLE AMYLASE HTL (described above), one gram of protease enzyme and one gram of beta-glucanase.
- the protease enzyme used in this example was PromodTM 144 GL, obtained from Biocatalysts Limited, located at Cefn Coed, Parc Nantgarw, CF15 7QQ, Wales, UK.
- PromodTM 144GL is a food-grade botanical protease with at least five proteases of different specificity, and can be used to modify protein functionality in food systems.
- the biological source of PromodTM 144GL is Carica papaya . It has an Activity rating of 100 Papain TU, and is provided in liquid form. PromodTM 144GL is designed to perform in the pH range 5.0-7.5, and is active at temperatures of 50-70° C. according to Biocatalysts Limited.
- PromodTM 144GL The exact level of application of PromodTM 144GL will depend on the protein substrate and the level of modification required. The degree of hydrolysis resulting from action upon a particular protein or protein system will be influenced by enzyme dose, pH, time and temperature. Trials are recommended to determine exact conditions for desired effect. For different degrees of hydrolysis, Biocatalysts Limited makes the following recommendations: high: 70-100 units/kg; moderate: 40-70 units/kg; and low: 20-50 units/kg based on protein weight. Varying pH, time and temperature can also influence the result. While PromodTM 144GL was used in this example, the invention is not limited to use of that product, and it will be apparent to persons skilled in the art that other suitable enzyme products can be used, including other protease enzyme products.
- the beta-glucanase used in this example was DepolTM 686L, also obtained from Biocatalysts Limited, identified above.
- DepolTM 686L is a food-grade broad-spectrum carbohydrase containing beta-glucanase and xylanase.
- the biological source of DepolTM 686L is Trichoderma sp. It has an Activity rating of 5,000 U/g (beta-glucanase), and is provided in the form of a brown liquid.
- DepolTM 686L is designed to perform in the pH range 3.0-6.5, and is active at temperatures of 50-65° C., according to Biocatalysts Limited.
- the pH value of the slurry after these additions measured 6.55 at 25° C.
- the slurry was then heated to 77° C. for thirty minutes and then raised to 88° C. and held for five minutes.
- the slurry was checked using an iodine test to determine that no starch remained in the slurry.
- Table 3 compares the NEI Totals from Table 2 to the SI Totals from Table 1. As clearly indicated in Table 3, the NEI Totals from the example Enhanced Enzyme Treatment were substantially higher than the SI Totals from the Standard Enzyme Treatment. Accordingly, applying an Enhanced Enzyme Treatment to an SRB isolate substantially increases yield and improves nutritional profile over and above applying Standard Enzyme Treatment. For example, but not by way of limitation, applying the above example Enhanced Enzyme Treatment to an SRB isolate increased decanted weight by 8.9 percent, increased solids by 59.8 percent, and increased dry basis weight by 73.1 percent, over and above applying Standard Enzyme Treatment. And with regard to nutritional profile, applying Enhanced Enzyme Treatment to an SRB isolate increased the yield of fats by 167.6 percent and the yield of proteins by 220.9 percent, over and above applying Standard Enzyme Treatment, as shown below in Table 3:
- one or more different enzymes can be introduced to the slurry in addition to, or instead of, the example enzymes described herein.
- a cellulase enzyme could be used, or any other suitable fiber and/or protein and/or fat-solublizing enzyme(s).
- the type of enzyme(s) and their relative dose(s) can be varied.
- the enzyme(s) can be introduced in a different form or phase at the same or different points in the process, and other variables can be adjusted as will be apparent to persons skilled in the art, including, pH, times, and temperatures.
- pH can be selected in the range from 5.5 to 5.8, while in other embodiments pH can be selected in the range from 5.0 to 7.5, while in yet other embodiments pH can be selected in the range from 3.0 to 6.5, and in still other embodiments pH can be selected in the range from 3.0 to 7.5. In one embodiment the pH is selected in the range 6.0 to 7.0. The invention is not limited to these pH ranges, however, unless specifically claimed. Trials are recommended to determine exact conditions for desired effect.
- the slurry was heated to 77° C. (the first temperature) for thirty minutes (the first time) and then raised to 88° C. (the second temperature) and held for five minutes (the second time).
- the first temperature can be selected in the range from 50° C. to 65° C.
- the first temperature can be selected in the range from 50° C. to 70° C.
- the first temperature can be selected in the range from 105° C. to 110° C.
- the first temperature can be selected in the range from 50° C. to 110° C.
- the first temperature is selected in the range from 57° C.
- the second temperature can be higher than, lower than, or the same as the first temperature. More specifically, in certain embodiments the second temperature can be selected in the range from 50° C. to 65° C., while in other embodiments the second temperature can be selected in the range from 50° C. to 70° C., while in yet other embodiments the second temperature can be selected in the range from 105° C. to 110° C., and in still other embodiments the second temperature can be selected in the range from 50° C. to 110° C. In one embodiment the second temperature is selected in the range from 68° C. to 108° C.
- the first and second times can each be varied in certain embodiments to be longer or shorter in duration than the other time, or the first and second times may have the same duration.
- the first and second times can each be selected in the range from 1 minute to 120 minutes.
- the first time is selected in the range from 15 to 45 minutes, and the second time is selected in the range from 1 to 10 minutes.
- Additional time durations e.g., third, fourth, etc.
- at various temperatures may be added, and/or any appropriate time-temperature curve or other shape may be used.
- the invention is not limited to any of the foregoing time or temperature ranges unless specifically claimed. Trials are recommended to determine exact conditions for desired effect. As understood in the art, references in the claims to isolating the various fractions does not require that all of the available material be isolated.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Compounds Of Unknown Constitution (AREA)
Abstract
Description
TABLE 1 |
Standard Isolate (SI) From Standard Enzyme Treatment (SET) |
Begin | Decant | % | Dry Basis | % As- | % As-Is | |
Wt. (g) | Wt. (g) | Solids | Weight | Is Fat | Protein | |
Sample 1 | 180 | 96 | 7.36 | 7.06 | 1.08 | 0.73 |
Sample 2 | 180 | 100 | 7.38 | 7.38 | 1.28 | 0.86 |
Sample 3 | 180 | 109 | 6.81 | 7.42 | 0.57 | 0.85 |
Sample 4 | 180 | 110 | 7.01 | 7.92 | 0.80 | 0.86 |
SI Totals/ | 720 | 415 | 7.14 | 7.45 | 0.93 | 0.83 |
Averages: | ||||||
2. Example Enhanced Enzyme Treatment (EET)
TABLE 2 |
Nutritionally Enhanced Isolate (NEI) From |
Enhanced Enzyme Treatment (EET) |
Begin | Decant | % | Dry Basis | % As- | % As-Is | |
Wt. (g) | Wt. (g) | Solids | Weight | Is Fat | Protein | |
Sample 1′ | 180 | 109 | 11.48 | 12.51 | 2.40 | 2.54 |
Sample 2′ | 180 | 113 | 11.65 | 13.16 | 2.43 | 2.55 |
Sample 3′ | 180 | 115 | 11.14 | 12.81 | 2.60 | 2.72 |
Sample 4′ | 180 | 115 | 11.37 | 13.08 | 2.55 | 2.78 |
NEI Totals/ | 720 | 452 | 11.41 | 12.89 | 2.50 | 2.65 |
Averages: | ||||||
TABLE 3 |
Improvement Of Nutritionally Enhanced Isolate (NEI) |
Over Standard Isolate (SI) |
Begin | Decant | % | Dry Basis | % As- | % As-Is | |
Wt. (g) | Wt. (g) | Solids | Weight | Is Fat | Protein | |
NEI Totals/ | 0 | 37 | 4.27 | 5.445 | 1.5625 | 1.8225 |
Averages less | ||||||
SI Totals/ | ||||||
Averages: | ||||||
NEI's % | 0.0% | 8.9% | 59.8% | 73.1% | 167.6% | 220.9% |
Increase | ||||||
Over SI | ||||||
Claims (6)
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/882,202 US8945642B2 (en) | 2010-09-15 | 2010-09-15 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
NI201100164A NI201100164A (en) | 2010-09-15 | 2011-08-26 | NUTRITIONALLY ENHANCED ISOLATE OF STABILIZED RICE BRAN AND PRODUCTION METHOD |
US13/494,998 US9192180B2 (en) | 2010-09-15 | 2012-06-13 | Nutritionally enhanced fraction from rice bran and method of lowering insulin resistance using same |
US14/573,688 US10238134B2 (en) | 2010-09-15 | 2014-12-17 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US14/923,666 US12219980B2 (en) | 2010-09-15 | 2015-10-27 | Nutritionally enhanced fraction from rice bran and method of lowering insulin resistance using same |
US16/271,425 US11039633B2 (en) | 2010-09-15 | 2019-02-08 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US16/573,561 US11540546B2 (en) | 2010-09-15 | 2019-09-17 | Nutraceuticals for the management of conditions related to type 2 diabetes |
US16/575,366 US11547135B2 (en) | 2010-09-15 | 2019-09-18 | Mitigation of chronic infant malnutrition |
US17/341,967 US11944113B2 (en) | 2010-09-15 | 2021-06-08 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US17/993,224 US20230115385A1 (en) | 2010-09-15 | 2022-11-23 | Nutraceuticals for the management of conditions related to type 2 diabetes |
US18/079,177 US20230165291A1 (en) | 2010-09-15 | 2022-12-12 | Mitigation of chronic infant malnutrition |
US18/623,700 US20240245081A1 (en) | 2010-09-15 | 2024-04-01 | Nutritionally Enhanced Isolate from Stabilized Rice Bran and Method of Production |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/882,202 US8945642B2 (en) | 2010-09-15 | 2010-09-15 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/494,998 Continuation-In-Part US9192180B2 (en) | 2010-09-15 | 2012-06-13 | Nutritionally enhanced fraction from rice bran and method of lowering insulin resistance using same |
US14/573,688 Continuation US10238134B2 (en) | 2010-09-15 | 2014-12-17 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
Publications (2)
Publication Number | Publication Date |
---|---|
US20120064191A1 US20120064191A1 (en) | 2012-03-15 |
US8945642B2 true US8945642B2 (en) | 2015-02-03 |
Family
ID=45806940
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/882,202 Active 2030-11-19 US8945642B2 (en) | 2010-09-15 | 2010-09-15 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US14/573,688 Active US10238134B2 (en) | 2010-09-15 | 2014-12-17 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US16/271,425 Active US11039633B2 (en) | 2010-09-15 | 2019-02-08 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US17/341,967 Active 2031-01-12 US11944113B2 (en) | 2010-09-15 | 2021-06-08 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US18/623,700 Pending US20240245081A1 (en) | 2010-09-15 | 2024-04-01 | Nutritionally Enhanced Isolate from Stabilized Rice Bran and Method of Production |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/573,688 Active US10238134B2 (en) | 2010-09-15 | 2014-12-17 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US16/271,425 Active US11039633B2 (en) | 2010-09-15 | 2019-02-08 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US17/341,967 Active 2031-01-12 US11944113B2 (en) | 2010-09-15 | 2021-06-08 | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US18/623,700 Pending US20240245081A1 (en) | 2010-09-15 | 2024-04-01 | Nutritionally Enhanced Isolate from Stabilized Rice Bran and Method of Production |
Country Status (2)
Country | Link |
---|---|
US (5) | US8945642B2 (en) |
NI (1) | NI201100164A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10238134B2 (en) | 2010-09-15 | 2019-03-26 | Qjv, Llc | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US20210260147A1 (en) * | 2020-02-25 | 2021-08-26 | Intermark Partners Strategic Management, Llc | Mitigation of chronic infant malnutrition |
US20220054577A1 (en) * | 2020-08-18 | 2022-02-24 | Intermark Partners Strategic Management, Llc | Maternal breast milk with natural bioactive nutraceutical extracts |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108541215A (en) * | 2016-02-11 | 2018-09-14 | 雀巢产品技术援助有限公司 | Vitamin composition |
KR102395172B1 (en) * | 2019-12-23 | 2022-05-10 | (주) 건우에프피 | Rice peptide complex with antihypertensive and antioxidant activity, and food composition comprising the same |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5985344A (en) | 1997-09-02 | 1999-11-16 | The Ricex Company | Process for obtaining micronutrient enriched rice bran oil |
US6126943A (en) | 1997-09-02 | 2000-10-03 | The Ricex Company | Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis |
US6303586B1 (en) | 1997-08-29 | 2001-10-16 | The Ricex Company | Supportive therapy for diabetes, hyperglycemia and hypoglycemia |
US6902739B2 (en) | 2001-07-23 | 2005-06-07 | Nutracea | Methods for treating joint inflammation, pain, and loss of mobility |
US20080038385A1 (en) | 2006-03-13 | 2008-02-14 | Nutracea | Therapeutic uses of an anti-cancer composition derived from rice bran |
US20090162514A1 (en) | 2007-12-21 | 2009-06-25 | Leo Gingras | Production of pasta using rice bran and rice flour |
US20090191308A1 (en) * | 2008-01-28 | 2009-07-30 | Gingras Leo G | Method of preparing emulsified cereal bran derivatives |
US20090220666A1 (en) | 2008-02-11 | 2009-09-03 | Leo Gingras | Utilization of stabilized bran in high protein products |
WO2009109703A1 (en) * | 2008-03-04 | 2009-09-11 | Polar Glucan Oy | Method of producing a bran product |
US20090285919A1 (en) | 2008-05-18 | 2009-11-19 | Alberte Randall S | Rice Bran Extracts for Inflammation and Methods of Use Thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8945642B2 (en) | 2010-09-15 | 2015-02-03 | Ike E. Lynch | Nutritionally enhanced isolate from stabilized rice bran and method of production |
-
2010
- 2010-09-15 US US12/882,202 patent/US8945642B2/en active Active
-
2011
- 2011-08-26 NI NI201100164A patent/NI201100164A/en unknown
-
2014
- 2014-12-17 US US14/573,688 patent/US10238134B2/en active Active
-
2019
- 2019-02-08 US US16/271,425 patent/US11039633B2/en active Active
-
2021
- 2021-06-08 US US17/341,967 patent/US11944113B2/en active Active
-
2024
- 2024-04-01 US US18/623,700 patent/US20240245081A1/en active Pending
Patent Citations (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6303586B1 (en) | 1997-08-29 | 2001-10-16 | The Ricex Company | Supportive therapy for diabetes, hyperglycemia and hypoglycemia |
US5985344A (en) | 1997-09-02 | 1999-11-16 | The Ricex Company | Process for obtaining micronutrient enriched rice bran oil |
US6126943A (en) | 1997-09-02 | 2000-10-03 | The Ricex Company | Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis |
US6350473B1 (en) | 1997-09-02 | 2002-02-26 | The Rice Company | Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis |
US6558714B2 (en) | 1997-09-02 | 2003-05-06 | The Ricex Company | Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis |
US6733799B2 (en) | 1997-09-02 | 2004-05-11 | The Ricex Company | Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis |
US6902739B2 (en) | 2001-07-23 | 2005-06-07 | Nutracea | Methods for treating joint inflammation, pain, and loss of mobility |
US20080038385A1 (en) | 2006-03-13 | 2008-02-14 | Nutracea | Therapeutic uses of an anti-cancer composition derived from rice bran |
US20090162514A1 (en) | 2007-12-21 | 2009-06-25 | Leo Gingras | Production of pasta using rice bran and rice flour |
US20090191308A1 (en) * | 2008-01-28 | 2009-07-30 | Gingras Leo G | Method of preparing emulsified cereal bran derivatives |
US20090220666A1 (en) | 2008-02-11 | 2009-09-03 | Leo Gingras | Utilization of stabilized bran in high protein products |
WO2009109703A1 (en) * | 2008-03-04 | 2009-09-11 | Polar Glucan Oy | Method of producing a bran product |
US20090285919A1 (en) | 2008-05-18 | 2009-11-19 | Alberte Randall S | Rice Bran Extracts for Inflammation and Methods of Use Thereof |
WO2009143064A2 (en) | 2008-05-18 | 2009-11-26 | Rice Science, Llc | Rice bran extracts for inflammation and methods of use thereof |
WO2009143065A2 (en) | 2008-05-18 | 2009-11-26 | Rice Science, Llc | Rice bran extracts and methods of use thereof |
US20100015258A1 (en) | 2008-05-18 | 2010-01-21 | Alberte Randall S | Rice Bran Extracts and Methods of Use Thereof |
WO2009143064A3 (en) | 2008-05-18 | 2010-04-01 | Rice Science, Llc | Rice bran extracts for inflammation and methods of use thereof |
WO2009143065A3 (en) | 2008-05-18 | 2010-04-22 | Rice Science, Llc | Rice bran extracts and methods of use thereof |
Non-Patent Citations (5)
Title |
---|
Hanmoungjai, P. et al. 2002. Enzyme-assisted water-extraction of oil and protein from rice bran. J. Chem. Tech. Biotech. 77:771-776. * |
Lynch, et al, How Does Diabatrol® Work?, White Paper, Jan. 8, 2010, passim. |
Qureshi, A.A. et al, 'Effects of stabilized rice bran, its soluble and fiber fractions, on blood glucose levels and serum lipid parameters in humans with diabetes mellitus Types I and II', Journal of Nutritional Biochemistry (2002) 13:175-187. |
Sharma, A. et al. 2001. Enzyme assisted aqueous extraction of rice bran oil. JAOCS. 78: 949-951. * |
Xianli Wu et al., in the Journal of Food Composition and Analysis 17 (2004) at pp. 407-422 (discussed in background of specification of present application.). |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10238134B2 (en) | 2010-09-15 | 2019-03-26 | Qjv, Llc | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US11039633B2 (en) | 2010-09-15 | 2021-06-22 | Qjv, Llc | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US11944113B2 (en) | 2010-09-15 | 2024-04-02 | Qjv, Llc | Nutritionally enhanced isolate from stabilized rice bran and method of production |
US20210260147A1 (en) * | 2020-02-25 | 2021-08-26 | Intermark Partners Strategic Management, Llc | Mitigation of chronic infant malnutrition |
US20220054577A1 (en) * | 2020-08-18 | 2022-02-24 | Intermark Partners Strategic Management, Llc | Maternal breast milk with natural bioactive nutraceutical extracts |
Also Published As
Publication number | Publication date |
---|---|
US10238134B2 (en) | 2019-03-26 |
NI201100164A (en) | 2012-08-02 |
US20210289822A1 (en) | 2021-09-23 |
US20190166891A1 (en) | 2019-06-06 |
US11039633B2 (en) | 2021-06-22 |
US20120064191A1 (en) | 2012-03-15 |
US20240245081A1 (en) | 2024-07-25 |
US11944113B2 (en) | 2024-04-02 |
US20150104541A1 (en) | 2015-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11944113B2 (en) | Nutritionally enhanced isolate from stabilized rice bran and method of production | |
Pineli et al. | Low glycemic index and increased protein content in a novel quinoa milk | |
Rodriguez-Solana et al. | Carob pulp: a nutritional and functional by-product worldwide spread in the formulation of different food products and beverages. A review | |
Wu et al. | Free and bound phenolic profiles of the bran from different rice varieties and their antioxidant activity and inhibitory effects on ɑ-amylose and ɑ-glucosidase | |
Maheshwari et al. | Extraction and isolation of β‐glucan from grain sources—A review | |
Liyanage et al. | Hypolipidemic and hypoglycemic potential of raw, boiled, and sprouted mung beans (Vigna radiata L. Wilczek) in rats | |
Donkor et al. | Rheological properties and sensory characteristics of set-type soy yogurt | |
Sanz et al. | In vitro investigation into the potential prebiotic activity of honey oligosaccharides | |
Ma et al. | Optimization of extraction efficiency by shear emulsifying assisted enzymatic hydrolysis and functional properties of dietary fiber from deoiled cumin (Cuminum cyminum L.) | |
RU2549932C2 (en) | Hydrolysed whole grains containing milk-and-grain beverage for young children | |
Calatayud et al. | Comparative effect of 22 dietary sources of fiber on gut microbiota of healthy humans in vitro | |
Powthong et al. | Study of prebiotic properties of selected banana species in Thailand | |
Chaiyasut et al. | Assessment of changes in the content of anthocyanins, phenolic acids, and antioxidant property of Saccharomyces cerevisiae mediated fermented black rice bran | |
Li et al. | Modulation of gelatinized wheat starch digestion and fermentation profiles by young apple polyphenols in vitro | |
Marpalle et al. | Nutritional characterization and oxidative stability of α-linolenic acid in bread containing roasted ground flaxseed | |
Mbithi-Mwikya et al. | Evaluation of the nutritional characteristics of a finger millet based complementary food | |
de Albuquerque et al. | Effects of digested flours from four different sweet potato (Ipomoea batatas L.) root varieties on the composition and metabolic activity of human colonic microbiota in vitro | |
RU2536911C1 (en) | Children alimentation products containing hydrolysed whole grains | |
Zhang et al. | Optimization of processing parameters for cloudy ginkgo (Ginkgo biloba Linn.) juice | |
Tian et al. | Effects of banana powder (Musa acuminata Colla) on the composition of human fecal microbiota and metabolic output using in vitro fermentation | |
RU2577356C2 (en) | Filling composition containing hydrolysed whole grains | |
Oliveira et al. | Valorization of grape by‐products as functional and nutritional ingredients for healthy pasta development | |
RU2550004C2 (en) | Hydrolysed whole grains containing grain products for young children | |
Fadaei et al. | Rice husk as a source of dietary fiber | |
US12161144B2 (en) | Process for preparation of cereal fractions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
AS | Assignment |
Owner name: PETERSON, JOESEPH C, INDIANA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:INTERMARK PARTNERS STRATEGIC MANAGEMENT, LLC;REEL/FRAME:036522/0915 Effective date: 20150908 |
|
AS | Assignment |
Owner name: INTERMARK PARTNERS STRATEGIC MANAGEMENT, LLC, INDI Free format text: CORRECTION BY DECLARATION: PREVIOUSLY RECORDED ON REEL 036522/FRAME 0915;ASSIGNOR:INTERMARK PARTNERS STRATEGIC MANAGEMENT, LLC;REEL/FRAME:036885/0979 Effective date: 20151008 |
|
AS | Assignment |
Owner name: INTERMARK PARTNERS STRATEGIC MANAGEMENT, LLC, INDI Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PETERSON, JOSEPH C;REEL/FRAME:040073/0656 Effective date: 20161019 |
|
AS | Assignment |
Owner name: PETERSON, JOSEPH C., INDIANA Free format text: SECURITY INTEREST;ASSIGNOR:INTERMARK PARTNERS STRATEGIC MANAGEMENT, LLC;REEL/FRAME:040634/0394 Effective date: 20160817 |
|
AS | Assignment |
Owner name: INTERMARK PARTNERS STRATEGIC MANAGEMENT, LLC, INDI Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:PETERSON, JOSEPH C;REEL/FRAME:043852/0045 Effective date: 20171011 |
|
AS | Assignment |
Owner name: INTERMARK PARTNERS STRATEGIC MANAGEMENT, LLC, INDI Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LYNCH, IKE E.;SULLIVAN, GLENN H.;MILLER, LARRY R.;SIGNING DATES FROM 20110801 TO 20110804;REEL/FRAME:043907/0279 |
|
AS | Assignment |
Owner name: QJV, LLC, MISSOURI Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:INTERMARK PARTNERS STRATEGIC MANAGEMENT, LLC;REEL/FRAME:044255/0367 Effective date: 20170925 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551) Year of fee payment: 4 |
|
FEPP | Fee payment procedure |
Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FEPP | Fee payment procedure |
Free format text: 7.5 YR SURCHARGE - LATE PMT W/IN 6 MO, SMALL ENTITY (ORIGINAL EVENT CODE: M2555); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2552); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Year of fee payment: 8 |
|
AS | Assignment |
Owner name: NUTRACEUTICAL TECHNOLOGIES INTERNATIONAL LLC, INDIANA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:INTERMARK PARTNERS STRATEGIC MANAGEMENT, LLC;REEL/FRAME:066079/0997 Effective date: 20240106 |